Tuberculin status, socioeconomic differences and differences in all-cause mortality: Experience from Norwegian cohorts born 1910-49

International Journal of Epidemiology

Volumn 38, Issue 2, 2009, Pages 427-434

  Liestøl, Knut ^a   Tretli, Steinar ^b   Tverdal, Aage ^c   Mæhlen, Jan ^d  

^a UNIVERSITY OF OSLO   (Norway)

^b CANCER REGISTRY OF NORWAY   (Norway)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^d ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Mass screening; Mortality; Socioeconomic factors; Tuberculosis

Indexed keywords

BCG VACCINE;

HEALTH RISK; INFECTIOUS DISEASE; MORTALITY; SOCIOECONOMIC INDICATOR; TUBERCULOSIS; VACCINATION;

ARTICLE; BCG VACCINATION; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; EDUCATIONAL STATUS; FEMALE; GEOGRAPHIC DISTRIBUTION; HIGH RISK POPULATION; HUMAN; INFECTION CONTROL; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MORTALITY; NORWAY; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; SOCIAL STATUS; SURVIVAL RATE; THORAX RADIOGRAPHY; TUBERCULIN TEST; TUBERCULOSIS; URBAN RURAL DIFFERENCE;

EURASIA; EUROPE; NORTHERN EUROPE; NORWAY; SCANDINAVIA;

EID: 64349086614     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyn347     Document Type: Article

References (24)

1. Backer JE. Dødeligheten og dens årsaker i Norge 1856-1955. Samfunnsøkonomiske studier 10, Central Bureau of Statistics, Oslo 1963 (in Norwegian).
2. Bjartveit K, Waaler HT. Some evidence of the efficacy of mass BCG vaccination. Bull WHO 1965;33:289-319.
3. Bjartveit K. Mass miniature radiography in Norway, today and in the future. Scand J Resp Dis 1972;80 (Suppl):31-42.
4. Bjartveit K, Foss OP, Gjervig T. The cardiovascular disease study in Norwegian counties. Results from first screening. Acta Med Scand 1983;675 (Suppl):1-184.
5. Statens skjermbildefotografering. Årsberetning for 1951 [Annual report 1951]. Oslo, 1954 (in Norwegian).
6. Waaler HT, Galtung O, Mordal K. The risk of tuberculosis infection in Norway. Tuberculosis surveillance Research Unit. Report no. 3. Bull Int Un Tuberc 1975;1:5-61.
7. Bjartveit K, Foss OP, Gjervig T, Lund-Larsen PG. The cardiovascular disease study in Norwegian counties. Background and organization. Acta Med Scand 1979;634 (Suppl):1-70.
8. Gjertsen F. Dødsårsaksregisteret - en viktig datakilde for medisinsk forskning. Tidskr Nor Laegeforen 2002;122:2551-54 (in Norwegian).
9. Central Bureau of Statistics. Population and Housing Census 1980, Vol II: Employment Statistics. Oslo, 1982.
10. Central Bureau of Statistics. Population and Housing Census 1980, Vol IV: Main results of the Censuses 1960, 1970 and 1980. Oslo, 1986.
11. Bjartveit K. The tuberculosis situation in Norway. Scand J Resp Dis 1978;102 (Suppl):28-35.
12. Heimbeck J. Tuberkuloseinfektion og tuberkulosevakcination. Tidsskr Nor Laegeforen 1928;48:946-61 (in Norwegian).
13. Bjartveit K. Olav Scheel and Johannes Heimbeck: Their contribution to understanding the pathogenesis and prevention of tuberculosis. Int J Tuberc Lung Dis 2003;7:306-11.
14. Cantwell MF, McKenna MT, McCray E, Onorato IM. Tuberculosis and race/ ethnicity in the United States; impact of socioeconomic status. Am J Respir Crit Care Med 1997;157:1016-20.
15. Bates I, Fenton C, Gruber J et al. Vulnerability to malaria, tuberculosis and HIV/AIDS infection and disease. Part 1: Determinants operation at individual and household level. Lancet Infect Dis 2004;4:267-77.
16. Lienhardt C, Fielding K, Sillah JS et al. Investigation of the risk factors for tuberculosis: A case-control study in three countries in West Africa. Int J Epidemiol 2005;34: 914-23.
17. Wilson LG. Commentary: Medicine, population, and tuberculosis. Int J Epidemiol 2005;34:521-24.
18. Tverdal A, Funnemark E. Protective effect of BCG vaccination in Norway 1956-73. Tubercle 1988;69: 119-23.
19. Joint Tuberculosis Committee of the British Thoracic Society. Control and prevention of tuberculosis in the United Kingdom: Code of practice 2000. Torax 2000;55: 887-901.
20. Rónneberg A, Lund KE, Hafstad A. Lifetime smoking habits among Norwegian men and women born between 1890 and 1974. Int J Epidemiol 1994;23:267-76.
21. Davies PDO, Yew WW, Ganguly D et al. Smoking and tuberculosis: The epidemiological association and immunopathogenesis. Trans R Soc of Trop Med Hyg 2006;100: 291-98.
22. Bates MN, Khalakdina A, Pai M et al. Risk of tuberculosis from exposure to tobacco smoke. A systematic review and meta-analysis. Arch Intern Med 2007;167:335-42.
23. Aaby P, Samb B, Simondon F et al. Non-specific beneficial effects of measles immunisation: Analysis of mortality studies from developing countries. Br Med J 1995;311: 481-85.
24. Roth AE, Stenballe LG, Garly ML, Aaby P. Beneficial non-targeted effects of BCG - ethical implications for the coming introduction of new TB vaccines. Tuberculosis 2006;86:397-403.